Metastatic clearcellrenalcellcancer has traditionally been treated with cytokines (interferon or interleukin-2).
2
Currently there is no curative treatment for metastatic clearcellrenalcellcancer, the commonest variant of the disease.
1
The patient had undergone a right radical nephrectomy for stage II clearcellcarcinomaofthekidney 6 years previously.
2
During the past decade, researchers have identified the von Hippel-Lindau (VHL) gene as an important tumor suppressor in clearcellcarcinomaofthekidney.
1
The predominant clear squamous neoplastic cells had foci of granular eosinophilic cytoplasm and resembled conventionalrenalcellcarcinoma.
2
A previously unreported feature is the occurrence of a conventionalrenalcellcarcinoma component in one of our cases.
1
These findings led to the diagnosis of simultaneous double primary clearcellcarcinomasofkidney and liver.
1
A total of 133 patients with early renalclearcellcarcinoma (T1-2N0M0) with surgical indications were continuously selected.
Ús de clear cell renal cell carcinoma en anglès
1
RCC-Ma expression is relatively specific for primary clearcellrenalcellcarcinoma.
2
Histologic examination revealed a metastatic clearcellrenalcellcarcinoma.
3
Current therapies for metastatic clearcellrenalcellcarcinoma (ccRCC) show limited efficacy.
4
She underwent radical nephrectomy and biopsy revealed clearcellrenalcellcarcinoma, Fuhrman grade 4.
5
Aim: A nine-year retrospective analysis of patients with clearcellrenalcellcarcinoma undergoing surgical treatment of pulmonary metastases.
6
However, its precise role in clearcellrenalcellcarcinoma (hereafter termed RCC) remains to be delineated.
7
Nuclear grade is one of the most important prognostic factors in clearcellrenalcellcarcinoma (CCRCC).
8
Patient summary: Cancer-specific RNA alternative splicing may portend a poor prognosis in patients with advanced clearcellrenalcellcarcinoma.
9
Materials and methods: We included 264 individuals who were diagnosed with non-metastatic clearcellrenalcellcarcinoma in the present study.
10
Importance: There are well-documented racial disparities in outcomes for African American patients with clearcellrenalcellcarcinoma (ccRCC).
11
Purpose: Tumor heterogeneity may represent a barrier to preoperative genomic characterization by needle biopsy in clearcellrenalcellcarcinoma (ccRCC).
12
A 71-year-old woman underwent right nephrectomy for the treatment of clearcellrenalcellcarcinoma at the age of 53.
13
Analysis of RNA-sequencing data revealed that bladder cancer had significantly lower levels of PSMA expression than both prostate cancer and clearcellrenalcellcarcinoma.
14
The aim of the study was to investigate the prognostic roles of intratumoral changes in surgical treated localized clearcellrenalcellcarcinoma (ccRCC).
15
We attempted to determine whether cytoplasmic fat in clearcellrenalcellcarcinoma (RCC) can be identified by chemical shift gradient-echo magnetic resonance imaging (CSI).
16
Materials and methods: We identified 1,864 patients who underwent partial or radical nephrectomy for nonmetastatic clearcellrenalcellcarcinoma between 1970 and 2000.